Olga Muratova - Concepedia

Concepedia

Author

Olga Muratova

National Institute of Allergy and Infectious Diseases

Also Known As

O Muratova, O. Muratova, O. V. Muratova, O.V. Muratova, Olga Muratova, Olga V Muratova, Olga V. Muratova

57

Publications

3.6K

Citations

32

H-Index

52

Concepts

All Affiliations

National Institute of Allergy and Infectious Diseases National Institutes of Health Johns Hopkins University Walter Reed Army Institute of Research Vector Oncology (United States)

OM

About

Olga Muratova is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, malaria, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	22	1.9K
2	Engineering	2	2	89
3	Natural Sciences	2	2	41
4	Health Sciences	1	1	56
5	Allergy	1	1	125

Olga Muratova

×

44

Publications

3.6K

Citations

32

H-Index

	Year	Citations
Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51 Yimin Wu, Ruth D. Ellis, Donna Shaffer, PLoS ONE	2008	450
Phase 1 Clinical Trial of Apical Membrane Antigen 1: an Asexual Blood-Stage Vaccine for <i>Plasmodium falciparum</i> Malaria Elissa Malkin, David Diemert, Julie H. McArthur, Infection and Immunity VaccinationAsexual Blood-stage VaccineVaccine DevelopmentAma1-c1 Malaria VaccineMalaria	2005	251
Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines Kazutoyo Miura, Andrew C. Orcutt, Olga Muratova, Vaccine VaccinationStandardized ElisaMalariaImmunologyReference Serum	2007	242
Disruption of <i>Plasmodium falciparum</i> development by antibodies against a conserved mosquito midgut antigen Rhoel R. Dinglasan, Dário Eluan Kalume, Stefan M. Kanzok, Proceedings of the National Academy of Sciences	2007	186
Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes Kim C. Williamson, David B. Keister, Olga Muratova, Molecular and Biochemical Parasitology African TrypanosomiasisAntiparasitic AgentPathogenesisImmunologyMalaria	1995	159
Immunity to Recombinant<i>Plasmodium falciparum</i>Merozoite Surface Protein 1 (MSP1): Protection in<i>Aotus nancymai</i>Monkeys Strongly Correlates with Anti-MSP1 Antibody Titer and In Vitro Parasite-Inhibitory Activity Sanjay Singh, Kazutoyo Miura, Hong Zhou, Infection and Immunity MalariaImmunologyImmunodominanceVitro Parasite-inhibitory ActivityImmune System	2006	146
Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults Kawsar R. Talaat, Ruth D. Ellis, Janet Hurd, PLoS ONE Vaccine ResearchMalariaImmunologyPlasmodium FalciparumParasite Genomics	2016	135
Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complex Yimin Wu, Craig T. Przysiecki, Elizabeth Flanagan, Proceedings of the National Academy of Sciences MalariaImmunologyHigh-titer Antibody ResponsesImmunodominancePlasmodium Falciparum	2006	125
Efficacy of Two Alternate Vaccines Based on<i>Plasmodium falciparum</i>Merozoite Surface Protein 1 in an<i>Aotus</i>Challenge Trial Anthony W. Stowers, Vittoria Cioce, Richard L. Shimp, Infection and Immunity VaccinationVaccine DevelopmentAllergyNeurovirologyVaccine Target	2001	125
Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230 Nicholas J. MacDonald, Vu Nguyen, Richard L. Shimp, Journal of Biological Chemistry	2016	107

Page 1